|
Volumn 132, Issue 8, 2008, Pages 1321-1324
|
Physician compliance with platelet usage criteria
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
ARTICLE;
BLEEDING;
CLINICAL PRACTICE;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY DISEASE;
HEALTH CARE COST;
HUMAN;
LUNG CANCER;
MAJOR CLINICAL STUDY;
MUCOSA INFLAMMATION;
PHYSICIAN;
POSTOPERATIVE CARE;
RISK;
SEPSIS;
THROMBOCYTE COUNT;
THROMBOCYTE TRANSFUSION;
THROMBOCYTOPENIA;
TREATMENT INDICATION;
GUIDELINE ADHERENCE;
HOSPITALS, TEACHING;
HUMANS;
PLATELET COUNT;
PLATELET TRANSFUSION;
PRACTICE GUIDELINES AS TOPIC;
RETROSPECTIVE STUDIES;
UNNECESSARY PROCEDURES;
|
EID: 49449111810
PISSN: 00039985
EISSN: 15432165
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (8)
|